Electrolyte and Acid-base disturbances induced by clacineurin inhibitors
- PMID: 24459511
- PMCID: PMC3894512
- DOI: 10.5049/EBP.2007.5.2.126
Electrolyte and Acid-base disturbances induced by clacineurin inhibitors
Abstract
Nephrotoxicity is the most common and clinically significant adverse effect of calcineurin inhibitors. Cyclosporine and tacrolimus nephrotoxicity is manifested by both acute azotemia and chronic progressive renal disease and tubular zdysfunction. An elevation in the plasma potassium concentration due to reduced efficiency of urinary potassium excretion is common in cyclosporine-treated patients; it may be severe and potentially life-threatening with concurrent administration of an angiotensin converting enzyme inhibitor, which diminishes aldosterone release. Tubular injury induced by cyclosporine can also impair acid excretion. This may be presented as a hyperchloremic metabolic acidosis associated with decreased aldosterone activity and suppression of ammonium excretion by hyperkalemia. Some patients treated with cyclosporine develop hypophosphatemia due to urinary phosphate wasting. Renal magnesium wasting is also common presumably due to drug effects on magnesium reabsorption. Hypomagnesemia has also been implicated as a contributor to the nephrotoxicity associated with cyclosporine. Both cyclosporine and tacrolimus are associated with hypercalciuria. Attention must be paid to drug dose, side effects, and drug interactions to minimize toxicity and maximize efficacy.
Keywords: Acidosis; Calcineurin inhibitors; Hypercalciuria; Hyperkalemia; Hypomagnesemia; Hypophosphatemia.
Figures



Similar articles
-
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.Kidney Int. 1996 Oct;50(4):1110-7. doi: 10.1038/ki.1996.417. Kidney Int. 1996. PMID: 8887267
-
Pathophysiology of chronic renal tubular acidosis induced by administration of amiloride.J Lab Clin Med. 1980 May;95(5):637-53. J Lab Clin Med. 1980. PMID: 7365313
-
Growth hormone corrects acidosis-induced renal nitrogen wasting and renal phosphate depletion and attenuates renal magnesium wasting in humans.Metabolism. 1999 Jun;48(6):763-70. doi: 10.1016/s0026-0495(99)90177-4. Metabolism. 1999. PMID: 10381152
-
[Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].Nephrologie. 1985;6(3):135-7. Nephrologie. 1985. PMID: 3908957 Review. French.
-
Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.Adv Chronic Kidney Dis. 2018 Jul;25(4):321-333. doi: 10.1053/j.ackd.2018.05.004. Adv Chronic Kidney Dis. 2018. PMID: 30139459 Review.
Cited by
-
Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease.Life (Basel). 2021 Nov 6;11(11):1200. doi: 10.3390/life11111200. Life (Basel). 2021. PMID: 34833076 Free PMC article.
-
Distal Renal Tubular Acidosis Accompanied by Severe Hypophosphatemia Mistaken as Fanconi Syndrome in a Kidney-Transplant Patient.Chonnam Med J. 2021 May;57(2):166-167. doi: 10.4068/cmj.2021.57.2.166. Epub 2021 May 24. Chonnam Med J. 2021. PMID: 34123751 Free PMC article. No abstract available.
-
An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers.Curr Cardiol Rev. 2022;18(6):e110522204611. doi: 10.2174/1573403X18666220511152330. Curr Cardiol Rev. 2022. PMID: 35546745 Free PMC article. Review.
-
Intercalated cell function, kidney innate immunity, and urinary tract infections.Pflugers Arch. 2024 Apr;476(4):565-578. doi: 10.1007/s00424-024-02905-4. Epub 2024 Jan 16. Pflugers Arch. 2024. PMID: 38227050 Review.
-
Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.Intern Emerg Med. 2018 Dec;13(8):1201-1209. doi: 10.1007/s11739-018-1898-7. Epub 2018 Jun 27. Intern Emerg Med. 2018. PMID: 29951810
References
-
- Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol. 2003;23:465–476. - PubMed
-
- Massry SG, Preuss HG, Maher JF, Schreiner GE. Renal tubular acidosis after cadaver kidney homotransplantation. Studies on mechanism. Am J Med. 1967;42:284–292. - PubMed
-
- Keven K, Ozturk R, Sengul S, Kutlay S, Ergun I, Erturk S, Erbay B. Renal tubular acidosis after kidney transplantation-incidence, risk factors and clinical implications. Nephrol Dial Transplant. 2007;22:906–910. - PubMed
-
- Yakupoglu HY, Corsenca A, Wahl P, Wüthrich RP, Ambühl PM. Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation. 2007;84:1151–1157. - PubMed
-
- Bartosh SM, Alonso EM, Whitington PF. Renal outcomes in pediatric liver transplantation. Clin Transplant. 1997;11:354–360. - PubMed
Publication types
LinkOut - more resources
Full Text Sources